(Q39934931)

English

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma.

scientific article published on January 2010

Statements

Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma. (English)
Tim Eisen
Uwe Trefzer
Anne Hamilton
Peter Hersey
Michael Millward
Robert D Knight
Jarl U Jungnelius
John Glaspy
1 January 2010
146-154

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit